LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

Oncogene

Volumn 22, Issue 8, 2003, Pages 1243-1246

  Li, Jie ^a,b   Zhang, Zhongqiu ^a   Dai, Zunyan ^a   Plass, Christoph ^a   Morrison, Carl ^a   Wang, Yian ^a   Wiest, Jonathan S ^c   Anderson, Marshall W ^c   You, Ming ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OncoImmune Ltd   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Loss of heterozygosity; Lung cancer; Mutations; Tumor suppressor; Wild type Kras2

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 12P; CODON; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; ONCOGENE K RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WILD TYPE;

ADENOCARCINOMA; ALLELES; CARCINOMA, LARGE CELL; CHROMOSOMES, HUMAN, PAIR 12; GENES, TUMOR SUPPRESSOR; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0037468253     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206192     Document Type: Article

References (36)

1. Anderson MW, Reynolds SH, You M and Maronpot RM. (1992). Environ. Health Perspect., 98, 13-24.
2. Baccichet A and Sinnett D. (1997). Br. J. Haematol., 99, 107-114.
3. Barbacid M. (1987). Annu. Rev. Biochem., 56, 779-827.
4. Beaupre DM and Kurzrock R. (1999). J. Clin. Oncol., 17, 1071-1079.
5. Beaupre DM, Talpaz M, Marini III FC, Cristiano RJ, Roth JA, Estrov Z, Albitar M, Freedman MH and Kurzrock R. (1999). Cancer Res., 59, 2971-2980.
6. Blin N and Stafford DW. (1976). Nucleic Acids Res., 3, 2303-2308.
7. Bos JL. (1989). Cancer Res., 49, 4682-4689.
8. Bremner R and Balmain A. (1990). Cell, 61, 407-417.
9. Buchmann A, Ruggeri B, Klein-Szanto AJ and Balmain A. (1991). Cancer Res., 51, 4097-4101.
10. Burmer GC, Rabinovitch PS and Loeb LA. (1991). Environ. Health Perspect., 93, 27-31.
11. De Gregorio L, Manenti G, Incarbone M, Pilotti S, Pastorino U, Pierotti MA and Dragani TA. (1998). Int. J. Cancer, 79, 269-272.
12. Dragani TA, Hirohashi S, Juji T, Kawajiri K, Kihara M, Ono-Kihara M, Manenti G, Nomoto T, Sugimura H, Genka K, Yokota J, Takahashi T, Mitsudomi T and Nagao M. (2000). Cancer Res., 15, 5017-5020.
13. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice M., Pierotti MA, Della Porta G, Binelli G and Dragani TA. (1993). Nat. Genet., 3, 132-136.
14. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW and Wiseman RW. (1994). Cancer Res., 54, 6257-6264.
15. Kiaris H. and Spandidos DA. (1995). Int. J. Oncol., 7, 413-421.
16. Kibel AS, Schutte M, Kern SE, Isaacs WB and Bova GS. (1998). Cancer Res., 58, 5652-5565.
17. Li S, Rosell R, Urban A, Font A, Ariza A, Armengol P, Abad A, Navas JJ and Monzo M. (1994). Lung Cancer, 11, 19-27.
18. Manenti G, Gariboldi M, Fiorino A, Zedda AI, Pierotti MA and Dragani TA. (1997). Mamm. Genome. 8, 801-804.
19. Mariyama M, Kishi K, Nakamura K, Obata H and Nishimura S. (1989). Jpn. J. Cancer Res., 80, 622-626.
20. Marshall CJ. (1991). Trends Genet., 7, 91-95.
21. Mills NE, Fishman CL, Rom WN, Dubin N and Jacobson DR. (1995). Cancer Res., 55, 1444-1447.
22. Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J and Wigler M. (1981). Cell, 27, 467-476.
23. Pinto MM, Emanuel JR, Chaturvedi V and Costa J. (1997). Acta. Cytol., 41, 427-434.
24. Reynolds SH, Anna CK, Brown KC, Wiest JS, Beattie EJ, Pero RW, Iglehart JD and Anderson MW. (1991). Proc. Natl. Acad. Sci. USA, 88, 1085-1089.
25. Rodenhuis S and Slebos RJ. (1992). Cancer Res., 52, 2665s-2669s.
26. Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC and Bos JL. (1988). Cancer Res., 48, 5738-5741.
27. Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove MM, Perucho M and Arnheimn N. (1990). Cancer Res., 50, 1279-1283.
28. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T. (1990). Oncogene, 5, 1037-1043.
29. Takeuchi S, Bartram CR, Miller CW, Reiter A, Seriu T, Zimmerann M, Schrappe M, Mori N, Slater J, Miyoshi I and Koeffler HP. (1996a). Blood, 87, 3368-3374.
30. Takeuchi S, Mori N, Koike M, Slater J, Park S, Miller CW, Miyoshi I and Koeffler HP. (1996b). Cancer Res., 56, 738-740.
31. Thompson TA, Haag JD, Lindstrom MJ, Griep AE, Lohse JK and Gould MN. (2002). Oncogene, 21, 2797-2804.
32. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL. (1988). N. Engl. J. Med., 319, 525-532.
33. Wang Y, Stoner G and You M. (1993). Cancer Res., 53, 1620-1624.
34. Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, Saito R and Yokota J. (2002). Carcinogenesis, 23, 1177-1183.
35. You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH and Anderson M (1992). Proc. Natl. Acad. Sci. USA, 89, 5804-5808.
36. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J, Anderson MW, Sills RC, Hong HL, Devereux TR, Jacks T, Guan KL and You M. (2001). Nat. Genet., 29, 25-33.